List of Tables
Table 1. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Trends
Table 2. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Drivers & Opportunity
Table 3. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Challenges
Table 4. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Restraints
Table 5. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Type
Table 9. Key Companies Time to Begin Mass Production of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Table 10. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Region (2019-2024) & (%)
Table 27. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value, (2025-2030) & (US$ Million)
Table 31. 1ST Biotherapeutics Basic Information List
Table 32. 1ST Biotherapeutics Description and Business Overview
Table 33. 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of 1ST Biotherapeutics (2019-2024)
Table 35. 1ST Biotherapeutics Recent Developments
Table 36. 3B Pharmaceuticals Basic Information List
Table 37. 3B Pharmaceuticals Description and Business Overview
Table 38. 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of 3B Pharmaceuticals (2019-2024)
Table 40. 3B Pharmaceuticals Recent Developments
Table 41. 3D-Micromac Basic Information List
Table 42. 3D-Micromac Description and Business Overview
Table 43. 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of 3D-Micromac (2019-2024)
Table 45. 3D-Micromac Recent Developments
Table 46. 3DMed Basic Information List
Table 47. 3DMed Description and Business Overview
Table 48. 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of 3DMed (2019-2024)
Table 50. 3DMed Recent Developments
Table 51. 3D Systems Basic Information List
Table 52. 3D Systems Description and Business Overview
Table 53. 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of 3D Systems (2019-2024)
Table 55. 3D Systems Recent Developments
Table 56. 10X Genomics Basic Information List
Table 57. 10X Genomics Description and Business Overview
Table 58. 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of 10X Genomics (2019-2024)
Table 60. 10X Genomics Recent Developments
Table 61. A*STAR Agency for Science Basic Information List
Table 62. A*STAR Agency for Science Description and Business Overview
Table 63. A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of A*STAR Agency for Science (2019-2024)
Table 65. A*STAR Agency for Science Recent Developments
Table 66. Technology and Research Basic Information List
Table 67. Technology and Research Description and Business Overview
Table 68. Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Technology and Research (2019-2024)
Table 70. Technology and Research Recent Developments
Table 71. A*STAR Institute of Microelectronics (IME) Basic Information List
Table 72. A*STAR Institute of Microelectronics (IME) Description and Business Overview
Table 73. A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of A*STAR Institute of Microelectronics (IME) (2019-2024)
Table 75. A*STAR Institute of Microelectronics (IME) Recent Developments
Table 76. A2A Pharmaceuticals Basic Information List
Table 77. A2A Pharmaceuticals Description and Business Overview
Table 78. A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of A2A Pharmaceuticals (2019-2024)
Table 80. A2A Pharmaceuticals Recent Developments
Table 81. Abbvie Basic Information List
Table 82. Abbvie Description and Business Overview
Table 83. Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Abbvie (2019-2024)
Table 85. Abbvie Recent Developments
Table 86. AbCellera Basic Information List
Table 87. AbCellera Description and Business Overview
Table 88. AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of AbCellera (2019-2024)
Table 90. AbCellera Recent Developments
Table 91. ABL Bio Basic Information List
Table 92. ABL Bio Description and Business Overview
Table 93. ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of ABL Bio (2019-2024)
Table 95. ABL Bio Recent Developments
Table 96. Abpro Basic Information List
Table 97. Abpro Description and Business Overview
Table 98. Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Abpro (2019-2024)
Table 100. Abpro Recent Developments
Table 101. Academy of Military Medical Sciences (China) Basic Information List
Table 102. Academy of Military Medical Sciences (China) Description and Business Overview
Table 103. Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 104. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Academy of Military Medical Sciences (China) (2019-2024)
Table 105. Academy of Military Medical Sciences (China) Recent Developments
Table 106. Accellix Basic Information List
Table 107. Accellix Description and Business Overview
Table 108. Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 109. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Accellix (2019-2024)
Table 110. Accellix Recent Developments
Table 111. Accord Healthcare Basic Information List
Table 112. Accord Healthcare Description and Business Overview
Table 113. Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 114. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Accord Healthcare (2019-2024)
Table 115. Accord Healthcare Recent Developments
Table 116. AccuGenomics Basic Information List
Table 117. AccuGenomics Description and Business Overview
Table 118. AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 119. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of AccuGenomics (2019-2024)
Table 120. AccuGenomics Recent Developments
Table 121. ACEA Biosciences Basic Information List
Table 122. ACEA Biosciences Description and Business Overview
Table 123. ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 124. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of ACEA Biosciences (2019-2024)
Table 125. ACEA Biosciences Recent Developments
Table 126. AC Immune Basic Information List
Table 127. AC Immune Description and Business Overview
Table 128. AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 129. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of AC Immune (2019-2024)
Table 130. AC Immune Recent Developments
Table 131. Acoustic MedSystems Basic Information List
Table 132. Acoustic MedSystems Description and Business Overview
Table 133. Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 134. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Acoustic MedSystems (2019-2024)
Table 135. Acoustic MedSystems Recent Developments
Table 136. Adaptimmune Basic Information List
Table 137. Adaptimmune Description and Business Overview
Table 138. Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 139. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Adaptimmune (2019-2024)
Table 140. Adaptimmune Recent Developments
Table 141. Aduro BioTech Basic Information List
Table 142. Aduro BioTech Description and Business Overview
Table 143. Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 144. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Aduro BioTech (2019-2024)
Table 145. Aduro BioTech Recent Developments
Table 146. Advaxis Basic Information List
Table 147. Advaxis Description and Business Overview
Table 148. Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 149. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Advaxis (2019-2024)
Table 150. Advaxis Recent Developments
Table 151. Adventus Ventures Basic Information List
Table 152. Adventus Ventures Description and Business Overview
Table 153. Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 154. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Adventus Ventures (2019-2024)
Table 155. Adventus Ventures Recent Developments
Table 156. Aerolase Basic Information List
Table 157. Aerolase Description and Business Overview
Table 158. Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 159. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Aerolase (2019-2024)
Table 160. Aerolase Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Downstream Customers
Table 164. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Distributors List
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
Table 168. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Picture
Figure 2. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 4. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Report Years Considered
Figure 5. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue in 2023
Figure 7. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Asset purchase Picture
Figure 9. Assignment Picture
Figure 10. Co-development Picture
Figure 11. Co-market Picture
Figure 12. Co-promotion Picture
Figure 13. Collaborative R&D Picture
Figure 14. Contract service Picture
Figure 15. CRADA Picture
Figure 16. Cross-licensing Picture
Figure 17. Others Picture
Figure 18. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value Market Share by Type, 2023 & 2030
Figure 20. Product Picture of Industry sector
Figure 21. Product Picture of Therapy areas
Figure 22. Product Picture of Technology type
Figure 23. Product Picture of Deal components
Figure 24. Product Picture of Financial terms
Figure 25. Product Picture of Stage of development
Figure 26. Product Picture of Others
Figure 27. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value Market Share by Application, 2023 & 2030
Figure 29. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 31. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 33. Asia Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 35. South America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 36. South America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 39. Key Countries/Regions Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value (%), (2019-2030)
Figure 40. United States Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 46. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 48. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 58. India Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 60. India Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 61. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Industrial Chain
Figure 62. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
